Skip to main content

Table 1 Demographic, clinical characteristics and laboratory parameters of COVID-19 patients and healthy subject*

From: Association of IL-10–592 C > A /-1082 A > G and the TNFα -308 G > A with susceptibility to COVID-19 and clinical outcomes

SNP_ID

IL10

rs1800872

(− 592)

IL10

rs1800896

(− 1082)

TNFa

rs1800629

(-308)

Genotypes/Variables

AA

CA

CC

p value

p value**

AA

AG

GG

p value

p value**

AG

GG

p value

Age (years, Mean ± SD)

56.2

 ± 16.3

58.4

 ± 13.2

50.1

 ± 22.9

0.4

P1 = 1

P2 = 1

P3 = 0.6

57.4

 ± 15.1

51.5 ± 13.6

59.5

 ± 16.3

0.23

P4 = 0.4

P5 = 1

P6 = 0.2

56.3

 ± 16.1

57.1

 ± 15.1

0.89

Sex

             

Male

25

30

2

0.6

-

33

8

16

0.52

 

14

43

0.19

Female

23

25

5

-

35

9

9

 

7

46

Diabetes Mellitus

             

Positive

22

25

2

0.8

-

28

10

13

0.39

-

7

42

0.34

Negative

27

30

4

-

41

7

11

-

13

48

Hypertension

             

Positive

19

23

1

0.4

-

28

7

8

0.8

-

4

39

0.04

Negative

30

32

5

-

41

10

16

-

16

51

CKD

    

-

    

-

   

Positive

1

0

1

0.015

-

2

0

0

0.54

-

0

2

0.50

Negative

48

55

5

-

67

17

24

-

20

88

PCR test

47

56

7

  

68

17

25

  

20

90

 

Positive

38(43%)

44

7

0.3965

 

52

14

23

0.2368

 

13

76

0.04536

Negative

9(19%)

12

0

 

16

3

2

 

7

14

White blood cell count (/µl)

11,020

 ± 0.04

11,091

 ± 0.04

10,000

 ± 0.001

0.7

P1 = 1

P2 = 1

P3 = 1

1.1159 ± 0.03

1.0588

 ± 0.05

1.0833 ± 0.05

0.75

P4 = 1

P5 = 1

P6-1

11,000 ± 0.06

11,000

 ± 0.03

1.0

Lymphocytes (/µl)

1820.3

 ± 618.9

11399.1

 ± 200.3

1197

 ± 259.8

0.7

P1 = 1

P2 = 1

P3 = 1

1129.8 ± 85.1

3845.4

 ± 1802.1

1249.9 ± 110.2

0.86

P4 = 0.003

P5 = 1

P6 = 0.019

1139.7

 ± 126.4

1672.6 ± 356.3

0.48

C reactive protein (mg/l)

81.3

 ± 9.3

63.6

 ± 9.1

66.4

± 26.8

0.3

P1 = 0.5

P2 = 1

P3 = 1

73.7

 ± 7.1

32.2

 ± 5.7

93.5

 ± 19.1

0.19

P4 = 0.05

P5 = 0.5

P6 = 0.01

69.4

 ± 14.6

72.1

 ± 7

0.87

Ferritin (ng/ml)

561.7

 ± 72.03

476.9

 ± 66.6

552.1

 ± 134.2

0.6

P1 = 1

P2 = 1

P3 = 1

556.2

 ± 61.1

352.5

 ± 73.9

529

 ± 110.1

0.81

P4 = 0.3

P5 = 1

P6 = 0.7

491.3

 ± 93

523.3

 ± 53.2

0.79

D-Dimer (ng/ml)

1282.4 ± 295.2

752.8 ± 138.1

1639 ± 731

0.1

P1 = 1

P2 = 0.2

P3 = 0.6

983.2

 ± 592.4

755.5 ± 272.4

1520.8 ± 463.2

0.13

P4 = 1

P5 = 0.3

P6 = 0.4

612.6

 ± 111.3

1131.4 ± 168.3

0.19

LDH (U/l)

423.3 ± 41.7

401.9 ± 45.8

330.3 ± 52.3

0.7

P1 = 1

P2 = 1

P3 = 1

415.3

 ± 40.5

307.1

 ± 39.8

458.1

 ± 61.1

0.56

P4 = 0.5

P5 = 1

P6 = 0.3

408.8

 ± 47.5

407.1

 ± 34.6

0.98

  1. *Demographic data were analyzed for COVID-19 patients (n = 110) and healthy subjects (n = 110), while laboratory and clinical characteristics were analyzed within the COVID-19 patients group (n = 110). **: Within group P1: difference between AA and CA, P2: difference between AA and CC, P3: difference between CA & CC. P4: difference between AA & AG, P5: difference between AA & GG, P6: difference between GG & AG Parameters described as mean ± SEM LDH: Lactate Dehydrogenase